{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:10:58Z","timestamp":1794107458251,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Organotypic cultures of tissue slices have been successfully established in lung, prostate, colon, gastric and breast cancer among other malignancies, but until now an<jats:italic>ex vivo<\/jats:italic>model based on tissue slices has not been established for uterine leiomyoma. In the present study, we describe a method for culturing tumour slides onto an alginate scaffold. Morphological integrity of tissue slices was maintained for up to 7 days of culture, with cells expressing desmin, estrogen and progesterone receptors. Driver mutations were present in the<jats:italic>ex vivo<\/jats:italic>slices at all-time points analyzed. Cultivated tumour slices responded to ovarian hormones stimulation upregulating the expression of genes involved in leiomyoma pathogenesis. This tissue model preserves extracellular matrix, cellular diversity and genetic background simulating more\u00a0<jats:italic>in-vivo-like<\/jats:italic>situations. As a novelty, this platform allows encapsulation of microspheres\u00a0containing drugs that can be tested on the<jats:italic>ex vivo<\/jats:italic>tumour slices. After optimizing drug release rates, microspheres would then be directly tested in animal models through local injection.<\/jats:p>","DOI":"10.1038\/s41598-020-62158-w","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T11:03:40Z","timestamp":1584961420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Organotypic culture as a research and preclinical model to study uterine leiomyomas"],"prefix":"10.1038","volume":"10","author":[{"given":"Ana","family":"Salas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-3257","authenticated-orcid":false,"given":"Ricardo","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"\u00c9vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Montes","family":"de Oca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"B\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7644-3436","authenticated-orcid":false,"given":"Teresa A.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"62158_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun, S. E. Uterine Fibroids. N. Engl. J. Med. 369, 1344\u20131355 (2013).","journal-title":"N. Engl. J. Med."},{"key":"62158_CR2","doi-asserted-by":"publisher","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","volume":"2","author":"EA Stewart","year":"2016","unstructured":"Stewart, E. A. et al. Uterine fibroids. Nat. Rev. Dis. Prim. 2, 16043, https:\/\/doi.org\/10.1038\/nrdp.2016.43 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"62158_CR3","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10815-012-9784-0","volume":"29","author":"G Levy","year":"2012","unstructured":"Levy, G. et al. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances. J. Assist. Reprod. Genet. 29, 703\u201312 (2012).","journal-title":"J. Assist. Reprod. Genet."},{"key":"62158_CR4","unstructured":"Taylor D. K. & Leppert C. P. Treatment for Uterine Fibroids: Searching for Effective Drug Therapies. 71, 233\u2013236 (2013)."},{"key":"62158_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/humupd\/dmx032","volume":"24","author":"MS Islam","year":"2018","unstructured":"Islam, M. S., Ciavattini, A., Petraglia, F., Castellucci, M. & Ciarmela, P. Extracellular matrix in uterine leiomyoma pathogenesis: A potential target for future therapeutics. Hum. Reprod. Update 24, 59\u201385 (2018).","journal-title":"Hum. Reprod. Update"},{"key":"62158_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-811X-8-1","volume":"8","author":"AB Moore","year":"2010","unstructured":"Moore, A. B. et al. Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type i production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun. Signal 8, 1\u201312 (2010).","journal-title":"Cell Commun. Signal"},{"key":"62158_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1056\/NEJMoa1302736","volume":"369","author":"M Mehine","year":"2013","unstructured":"Mehine, M. et al. Characterization of Uterine Leiomyomas by Whole-Genome Sequencing. N. Engl. J. Med. 369, 43\u201353 (2013).","journal-title":"N. Engl. J. Med."},{"key":"62158_CR8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1073\/pnas.1518752113","volume":"113","author":"M Mehine","year":"2016","unstructured":"Mehine, M. et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc. Natl. Acad. Sci. 113, 1315\u20131320 (2016).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62158_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.fertnstert.2012.04.044","volume":"98","author":"A Mas","year":"2012","unstructured":"Mas, A. et al. Identification and characterization of the human leiomyoma side population as putative tumor-initiating cells. Fertil. Steril. 98, 741\u2013751.e6 (2012).","journal-title":"Fertil. Steril."},{"key":"62158_CR10","doi-asserted-by":"publisher","first-page":"17053","DOI":"10.1073\/pnas.1313650110","volume":"110","author":"M Ono","year":"2013","unstructured":"Ono, M. et al. Paracrine activation of WNT\/-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc. Natl. Acad. Sci. 110, 17053\u201317058 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62158_CR11","doi-asserted-by":"publisher","first-page":"e36935","DOI":"10.1371\/journal.pone.0036935","volume":"7","author":"M Ono","year":"2012","unstructured":"Ono, M. et al. Role of stem cells in human uterine leiomyoma growth. PLoS One 7, e36935, https:\/\/doi.org\/10.1371\/journal.pone.0036935 (2012).","journal-title":"PLoS One"},{"key":"62158_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/molehr\/gau022","volume":"20","author":"M Drosch","year":"2014","unstructured":"Drosch, M. et al. The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids. Mol. Hum. Reprod 20, 664\u2013676 (2014).","journal-title":"Mol. Hum. Reprod"},{"key":"62158_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmu048","volume":"21","author":"MB Moravek","year":"2015","unstructured":"Moravek, M. B. et al. Ovarian steroids, stem cells and uterine leiomyoma: Therapeutic implications. Hum. Reprod. Update 21, 1\u201312 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"62158_CR14","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1158\/0008-5472.CAN-17-1744","volume":"77","author":"X Wu","year":"2017","unstructured":"Wu, X. et al. Subtype-specific tumor-associated fibroblasts contribute to the pathogenesis of uterine leiomyoma. Cancer Res. 77, 6891\u20136901 (2017).","journal-title":"Cancer Res."},{"key":"62158_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/molehr\/2.11.823","volume":"2","author":"MF Severino","year":"1996","unstructured":"Severino, M. F. et al. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol Hum Reprod 2, 823\u2013828 (1996).","journal-title":"Mol Hum Reprod"},{"key":"62158_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/molehr\/gal018","volume":"12","author":"M Zaitseva","year":"2006","unstructured":"Zaitseva, M., Vollenhoven, B. J. & Rogers, P. A. W. In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. Mol. Hum. Reprod 12, 187\u2013207 (2006).","journal-title":"Mol. Hum. Reprod"},{"key":"62158_CR17","first-page":"549","volume":"550","author":"Markowski","year":"2016","unstructured":"Markowski et al. Cell cultures in Uterine Leiomyomas: Rapid disappearance of cells carrying MED12 mutations. Genes Chromosomes Cancer 550, 549\u2013550 (2016).","journal-title":"Genes Chromosomes Cancer"},{"key":"62158_CR18","doi-asserted-by":"publisher","first-page":"34762","DOI":"10.18632\/oncotarget.16711","volume":"8","author":"J Bloch","year":"2017","unstructured":"Bloch, J., Holzmann, C., Koczan, D., Helmke, B. M. & Bullerdiek, J. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth. Oncotarget 8, 34762\u201334772 (2017).","journal-title":"Oncotarget"},{"key":"62158_CR19","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1073\/pnas.0907676107","volume":"107","author":"V Vaira","year":"2010","unstructured":"Vaira, V. et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc. Natl. Acad. Sci. 107, 8352\u20138356 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"62158_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpb.2016.11.013","volume":"112","author":"L Merz","year":"2017","unstructured":"Merz, L. et al. Tumor tissue slice cultures as a platform for analyzing tissue-penetration and biological activities of nanoparticles. Eur. J. Pharm. Biopharm. 112, 45\u201350 (2017).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"62158_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ten.teb.2012.0437","volume":"19","author":"QL Loh","year":"2013","unstructured":"Loh, Q. L. & Choong, C. Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size. Tissue Eng. Part B Rev 19, 485\u2013502 (2013).","journal-title":"Tissue Eng. Part B Rev"},{"key":"62158_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s13346-018-0574-9","volume":"8","author":"E Segredo-Morales","year":"2018","unstructured":"Segredo-Morales, E., Reyes, R., Arnau, M. R., Delgado, A. & \u00c9vora, C. In situ gel-forming system for dual BMP-2 and 17\u03b2-estradiol controlled release for bone regeneration in osteoporotic rats. Drug Deliv. Transl. Res. 8, 1103\u20131113 (2018).","journal-title":"Drug Deliv. Transl. Res."},{"key":"62158_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ijpharm.2018.03.034","volume":"543","author":"E Segredo-Morales","year":"2018","unstructured":"Segredo-Morales, E. et al. Bone regeneration in osteoporosis by delivery BMP-2 and PRGF from tetronic\u2013alginate composite thermogel. Int. J. Pharm. 543, 160\u2013168 (2018).","journal-title":"Int. J. Pharm."},{"key":"62158_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jconrel.2020.01.028","volume":"320","author":"F Molavi","year":"2020","unstructured":"Molavi, F., Barzegar-Jalali, M. & Hamishehkar, H. Polyester based polymeric nano and microparticles for pharmaceutical purposes: A review on formulation approaches. Journal of Controlled Release 320, 265\u2013282 (2020).","journal-title":"Journal of Controlled Release"},{"key":"62158_CR25","first-page":"2192","volume":"83","author":"Y Shimomura","year":"1998","unstructured":"Shimomura, Y., Matsuo, H., Samoto, T. & Maruo, T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J. Clin. Endocrinol. Metab. 83, 2192\u20132198 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"62158_CR26","doi-asserted-by":"crossref","unstructured":"Ishikawa, H. et al. Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma. 151, 2433\u20132442 (2017).","DOI":"10.1210\/en.2009-1225"},{"issue":"2","key":"62158_CR27","doi-asserted-by":"publisher","first-page":"FSO190","DOI":"10.4155\/fsoa-2017-0003","volume":"3","author":"TG Meijer","year":"2017","unstructured":"Meijer, T. G., Jager, A. & Gent, D. C. Van. Ex vivo tumor culture systems for functional drug testing and therapy response prediction. Future Sci OA. 27 3(2), FSO190 (2017).","journal-title":"Future Sci OA. 27"},{"key":"62158_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-016-2119-2","volume":"16","author":"KAT Naipal","year":"2016","unstructured":"Naipal, K. A. T. et al. Tumor slice culture system to assess drug response of primary breast cancer. BMC Cancer 16, 1\u201313 (2016).","journal-title":"BMC Cancer"},{"key":"62158_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/molehr\/gau114","volume":"21","author":"A Mas","year":"2014","unstructured":"Mas, A. et al. Overexpression of the truncated form of high mobility group a proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation. Mol. Hum. Reprod 21, 330\u2013338 (2014).","journal-title":"Mol. Hum. Reprod"},{"key":"62158_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng0895-436","volume":"10","author":"EFPM Schoenmakers","year":"1995","unstructured":"Schoenmakers, E. F. P. M. et al. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat. Genet. 10, 436\u2013444 (1995).","journal-title":"Nat. Genet."},{"key":"62158_CR31","doi-asserted-by":"publisher","first-page":"7453","DOI":"10.1158\/0008-5472.CAN-06-0931","volume":"66","author":"MR Zaidi","year":"2006","unstructured":"Zaidi, M. R., Okada, Y. & Chada, K. K. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice. Cancer Res. 66, 7453\u20137459 (2006).","journal-title":"Cancer Res."},{"key":"62158_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8935-5-13","volume":"5","author":"T Prenzel","year":"2012","unstructured":"Prenzel, T. et al. Cohesin is required for expression of the estrogen receptor-alpha (ESR1) gene. Epigenetics and Chromatin 5, 1\u201313 (2012).","journal-title":"Epigenetics and Chromatin"},{"key":"62158_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/humupd\/dmh019","volume":"10","author":"T Maruo","year":"2004","unstructured":"Maruo, T., Ohara, N., Wang, J. & Matsuo, H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum. Reprod. Update 10, 207\u2013220 (2004).","journal-title":"Hum. Reprod. Update"},{"key":"62158_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-6-1","volume":"6","author":"H Van Der Kuip","year":"2006","unstructured":"Van Der Kuip, H. et al. Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment. BMC Cancer 6, 1\u201311 (2006).","journal-title":"BMC Cancer"},{"key":"62158_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/bjc.2013.700","volume":"110","author":"MM Gerlach","year":"2014","unstructured":"Gerlach, M. M. et al. Slice cultures from head and neck squamous cell carcinoma: A novel test system for drug susceptibility and mechanisms of resistance. Br. J. Cancer 110, 479\u2013488 (2014).","journal-title":"Br. J. Cancer"},{"key":"62158_CR36","first-page":"1","volume":"2015","author":"E Viveros-Valdez","year":"2015","unstructured":"Viveros-Valdez, E. et al. Organotypic Culture of Breast Tumor Explants as a Multicellular System for the Screening of Natural Compounds with Antineoplastic Potential. Biomed Res. Int 2015, 1\u201313 (2015).","journal-title":"Biomed Res. Int"},{"key":"62158_CR37","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/cam4.720","volume":"5","author":"J Koerfer","year":"2016","unstructured":"Koerfer, J. et al. Organotypic slice cultures of human gastric and esophagogastric junction cancer. Cancer Med 5, 1444\u20131453 (2016).","journal-title":"Cancer Med"},{"key":"62158_CR38","first-page":"2275","volume":"86","author":"O Kurachi","year":"2001","unstructured":"Kurachi, O., Matsuo, H., Samoto, T. & Maruo, T. Tumor necrosis factor alpha expression in human uterine leiomyoma and its down-regulation by progesterone. J. Clin. Endocrinol. Metab. 86, 2275\u20132280 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"62158_CR39","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jneumeth.2017.02.002","volume":"280","author":"AM Kopec","year":"2017","unstructured":"Kopec, A. M., Rivera, P. D., Lacagnina, M. J., Hanamsagar, R. & Bilbo, S. D. Optimized solubilization of TRIzol-precipitated protein permits Western blotting analysis to maximize data available from brain tissue. J. Neurosci. Methods. 280, 64\u201376 (2017).","journal-title":"J. Neurosci. Methods."},{"key":"62158_CR40","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.ygyno.2018.07.007","volume":"150","author":"LJ Galindo","year":"2018","unstructured":"Galindo, L. J. et al. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol. Oncol. 150, 562\u2013568 (2018).","journal-title":"Gynecol. Oncol."},{"key":"62158_CR41","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K Tamura","year":"2013","unstructured":"Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol. Biol. Evol 30, 2725\u20139 (2013).","journal-title":"Mol. Biol. Evol"},{"key":"62158_CR42","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4049\/jimmunol.121.3.1007","volume":"121","author":"JD Thompson","year":"1978","unstructured":"Thompson, J. D., Higgins, D. J., Gibson, T. J. & CLUSTAL, W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. J. Immunol. 121, 1007\u20139 (1978).","journal-title":"J. Immunol."},{"key":"62158_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ygyno.2014.04.012","volume":"134","author":"TA Almeida","year":"2014","unstructured":"Almeida, T. A. et al. Gynecologic Oncology A high-throughput open-array qPCR gene panel to identify housekeeping genes suitable for myometrium and leiomyoma expression analysis. Gynecol. Oncol. 134, 138\u2013143 (2014).","journal-title":"Gynecol. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62158-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62158-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T23:58:59Z","timestamp":1695945539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62158-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62158-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5212"}}